Inventor
PALMER NICHOLAS JOHN
GB24 patents
⚠️ This page may combine multiple inventors who share the name “PALMER NICHOLAS JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
15 patentsUS10287258B2May 14, 2019
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB18 citations97
US9522894B2Dec 20, 2016
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB25 citations97
US11773069B2Oct 3, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB6 citations94
US11117874B2Sep 14, 2021
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB15 citations93
US10669245B2Jun 2, 2020
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB16 citations93
US12054465B2Aug 6, 2024
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB3 citations85
US11814359B2Nov 14, 2023
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB4 citations85
US11680049B2Jun 20, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673872B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11673871B2Jun 13, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11667615B2Jun 6, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655224B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655223B2May 23, 2023
Certain (2S)-N-[(1 s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655221B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations85
US11655222B2May 23, 2023
Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase 1 inhibitors
ASTRAZENECA AB5 citations84
XENTION LTD
3 patentsUS7456187B2Nov 25, 2008
Furanopyrimidine compounds as potassium ion channel inhibitors
XENTION LTD42 citations91
US8022076B2Sep 20, 2011
Substituted thieno[2,3-d]pyrimidines as potassium channel inhibitors
XENTION LTD21 citations79
US7576212B2Aug 18, 2009
Thieno[2,3-B] pyridines as potassium channel inhibitors
XENTION LTD3 citations59